mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.004 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |